Quarterly Result14 May 2026, 02:14 pm
Senores Pharma: Audited FY26 Financial Results Approved
AI Summary
Senores Pharmaceuticals Ltd. announced the approval of audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026, with an unmodified opinion from auditors M/s. Pankaj R. Shah and Associates. The company also announced the resignation of Company Secretary and Compliance Officer Mr. Vinay Kumar Mishra, effective June 10, 2026, and the appointment of Sharp & Tannan Associates as the Internal Auditor for FY 2026-27.
Key Highlights
- Audited financial results for FY26 approved with an unmodified audit opinion.
- Vinay Kumar Mishra resigned as Company Secretary & Compliance Officer, effective June 10, 2026.
- Sharp & Tannan Associates appointed as Internal Auditor for FY 2026-27.
- Financial results and auditor's report are enclosed as Annexure-A.
- Media release related to the financial results is enclosed as Annexure-B.
Price Impact
More from SENORES